Decade-long remission after CAR T cell therapy

An analysis of two patients published in Nature from Penn researchers and colleagues from Children’s Hospital of Philadelphia explains the longest persistence of CAR T cell therapy recorded to date against CLL, and shows that the CAR T cells remained detectable at least a decade after infusion, with sustained remission in both patients

Read more in Penn Today and:

• NY Times
• Philadelphia Inquirer